nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—Dimetacrine—Tamoxifen—breast cancer	0.502	0.571	CrCrCtD
Cyamemazine—Promazine—Tamoxifen—breast cancer	0.376	0.429	CrCrCtD
Cyamemazine—Trifluoperazine—S100A4—breast cancer	0.00388	0.19	CrCbGaD
Cyamemazine—Dimetacrine—ACHE—breast cancer	0.00267	0.131	CrCbGaD
Cyamemazine—Ethopropazine—BCHE—breast cancer	0.000934	0.0456	CrCbGaD
Cyamemazine—Clomipramine—GSTP1—breast cancer	0.000784	0.0383	CrCbGaD
Cyamemazine—Triflupromazine—BCHE—breast cancer	0.000765	0.0374	CrCbGaD
Cyamemazine—Mequitazine—CYP2D6—breast cancer	0.000525	0.0256	CrCbGaD
Cyamemazine—Alimemazine—CYP3A4—breast cancer	0.000523	0.0255	CrCbGaD
Cyamemazine—Diltiazem—CYP2D6—breast cancer	0.000471	0.023	CrCbGaD
Cyamemazine—Mequitazine—CYP3A4—breast cancer	0.00045	0.022	CrCbGaD
Cyamemazine—Diltiazem—CYP3A4—breast cancer	0.000404	0.0197	CrCbGaD
Cyamemazine—Pipotiazine—CYP2D6—breast cancer	0.000374	0.0182	CrCbGaD
Cyamemazine—Chlorpromazine—BCHE—breast cancer	0.000369	0.018	CrCbGaD
Cyamemazine—Mesoridazine—CYP2D6—breast cancer	0.000369	0.018	CrCbGaD
Cyamemazine—Prochlorperazine—CYP2D6—breast cancer	0.000357	0.0174	CrCbGaD
Cyamemazine—Diltiazem—ABCB1—breast cancer	0.000336	0.0164	CrCbGaD
Cyamemazine—Fluphenazine—CYP2D6—breast cancer	0.000323	0.0158	CrCbGaD
Cyamemazine—Pipotiazine—CYP3A4—breast cancer	0.00032	0.0156	CrCbGaD
Cyamemazine—Prochlorperazine—CYP3A4—breast cancer	0.000306	0.0149	CrCbGaD
Cyamemazine—Triflupromazine—ABCB1—breast cancer	0.0003	0.0146	CrCbGaD
Cyamemazine—Clomipramine—CYP2D6—breast cancer	0.000295	0.0144	CrCbGaD
Cyamemazine—Acepromazine—ALB—breast cancer	0.000291	0.0142	CrCbGaD
Cyamemazine—Thioproperazine—ALB—breast cancer	0.000284	0.0139	CrCbGaD
Cyamemazine—Pipotiazine—ALB—breast cancer	0.000279	0.0136	CrCbGaD
Cyamemazine—Thioridazine—CYP2D6—breast cancer	0.000278	0.0136	CrCbGaD
Cyamemazine—Trimipramine—CYP2D6—breast cancer	0.000272	0.0133	CrCbGaD
Cyamemazine—Methotrimeprazine—CYP2D6—breast cancer	0.000266	0.013	CrCbGaD
Cyamemazine—Promethazine—CYP2D6—breast cancer	0.000262	0.0128	CrCbGaD
Cyamemazine—Perphenazine—CYP2D6—breast cancer	0.000255	0.0125	CrCbGaD
Cyamemazine—Clomipramine—CYP3A4—breast cancer	0.000253	0.0124	CrCbGaD
Cyamemazine—Trimipramine—CYP3A4—breast cancer	0.000233	0.0114	CrCbGaD
Cyamemazine—Fluphenazine—ABCB1—breast cancer	0.000231	0.0113	CrCbGaD
Cyamemazine—Clomipramine—ALB—breast cancer	0.000221	0.0108	CrCbGaD
Cyamemazine—Perphenazine—CYP3A4—breast cancer	0.000219	0.0107	CrCbGaD
Cyamemazine—Clomipramine—ABCB1—breast cancer	0.000211	0.0103	CrCbGaD
Cyamemazine—Chlorprothixene—ABCB1—breast cancer	0.00021	0.0102	CrCbGaD
Cyamemazine—Chlorpromazine—CYP2D6—breast cancer	0.000203	0.00989	CrCbGaD
Cyamemazine—Imipramine—CYP2D6—breast cancer	0.000201	0.00984	CrCbGaD
Cyamemazine—Promazine—CYP3A4—breast cancer	0.000197	0.00964	CrCbGaD
Cyamemazine—Trimipramine—ABCB1—breast cancer	0.000194	0.00947	CrCbGaD
Cyamemazine—Promethazine—ABCB1—breast cancer	0.000187	0.00912	CrCbGaD
Cyamemazine—Trifluoperazine—ABCB1—breast cancer	0.000184	0.009	CrCbGaD
Cyamemazine—Chlorpromazine—CYP3A4—breast cancer	0.000174	0.00848	CrCbGaD
Cyamemazine—Imipramine—CYP3A4—breast cancer	0.000173	0.00844	CrCbGaD
Cyamemazine—Chlorpromazine—ALB—breast cancer	0.000152	0.0074	CrCbGaD
Cyamemazine—Chlorpromazine—ABCB1—breast cancer	0.000145	0.00706	CrCbGaD
Cyamemazine—Imipramine—ABCB1—breast cancer	0.000144	0.00702	CrCbGaD
Cyamemazine—HTR2C—Signaling Pathways—NCOR1—breast cancer	3.02e-05	0.000296	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AKT2—breast cancer	3.01e-05	0.000296	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGF10—breast cancer	3e-05	0.000295	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLG—breast cancer	2.99e-05	0.000294	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CSF2—breast cancer	2.98e-05	0.000293	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGF1—breast cancer	2.98e-05	0.000293	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—RAF1—breast cancer	2.97e-05	0.000292	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NRG1—breast cancer	2.96e-05	0.000291	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AKT2—breast cancer	2.96e-05	0.000291	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGF10—breast cancer	2.94e-05	0.000289	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—H2AFX—breast cancer	2.94e-05	0.000289	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—IL2—breast cancer	2.94e-05	0.000289	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—E2F1—breast cancer	2.92e-05	0.000287	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PIK3CB—breast cancer	2.9e-05	0.000286	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PIK3CD—breast cancer	2.89e-05	0.000284	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PDGFA—breast cancer	2.89e-05	0.000284	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFBR2—breast cancer	2.85e-05	0.00028	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	2.84e-05	0.000279	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PDGFA—breast cancer	2.84e-05	0.000279	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ITPR1—breast cancer	2.8e-05	0.000276	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SPP1—breast cancer	2.8e-05	0.000276	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFBR2—breast cancer	2.8e-05	0.000275	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCL8—breast cancer	2.79e-05	0.000274	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—STAT5A—breast cancer	2.78e-05	0.000274	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ERBB4—breast cancer	2.78e-05	0.000274	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP3—breast cancer	2.78e-05	0.000274	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PIK3CB—breast cancer	2.78e-05	0.000273	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ERBB3—breast cancer	2.77e-05	0.000273	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGFR2—breast cancer	2.77e-05	0.000272	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ITPR1—breast cancer	2.75e-05	0.000271	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—STAT5A—breast cancer	2.73e-05	0.000269	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ERBB4—breast cancer	2.73e-05	0.000269	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP3—breast cancer	2.73e-05	0.000269	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	2.73e-05	0.000268	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SMAD4—breast cancer	2.7e-05	0.000265	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1R—breast cancer	2.68e-05	0.000264	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCL8—breast cancer	2.67e-05	0.000262	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL2—breast cancer	2.67e-05	0.000262	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TERT—breast cancer	2.66e-05	0.000261	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SMAD4—breast cancer	2.65e-05	0.00026	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HES1—breast cancer	2.63e-05	0.000259	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1R—breast cancer	2.63e-05	0.000259	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	2.62e-05	0.000258	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLA2G4A—breast cancer	2.62e-05	0.000257	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NCOR1—breast cancer	2.62e-05	0.000257	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CSF2—breast cancer	2.59e-05	0.000255	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGF1—breast cancer	2.59e-05	0.000255	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HES1—breast cancer	2.59e-05	0.000254	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—RAF1—breast cancer	2.58e-05	0.000254	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FGFR1—breast cancer	2.58e-05	0.000254	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	2.57e-05	0.000253	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NCOR1—breast cancer	2.57e-05	0.000253	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NRG1—breast cancer	2.57e-05	0.000253	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—H2AFX—breast cancer	2.55e-05	0.000251	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—IL2—breast cancer	2.55e-05	0.000251	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CSF2—breast cancer	2.54e-05	0.00025	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGF1—breast cancer	2.54e-05	0.00025	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HIF1A—breast cancer	2.54e-05	0.00025	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—RAF1—breast cancer	2.54e-05	0.000249	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—E2F1—breast cancer	2.53e-05	0.000249	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NRG1—breast cancer	2.52e-05	0.000248	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PIK3CB—breast cancer	2.52e-05	0.000248	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—H2AFX—breast cancer	2.51e-05	0.000246	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—IL2—breast cancer	2.5e-05	0.000246	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—E2F1—breast cancer	2.49e-05	0.000245	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LEP—breast cancer	2.48e-05	0.000244	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	2.48e-05	0.000243	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CAV1—breast cancer	2.46e-05	0.000242	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SPP1—breast cancer	2.43e-05	0.000239	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KDR—breast cancer	2.43e-05	0.000239	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCL8—breast cancer	2.42e-05	0.000238	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ERBB3—breast cancer	2.41e-05	0.000237	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGFR2—breast cancer	2.4e-05	0.000236	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SPP1—breast cancer	2.39e-05	0.000235	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCL8—breast cancer	2.38e-05	0.000234	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ESR1—breast cancer	2.37e-05	0.000233	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ERBB3—breast cancer	2.36e-05	0.000232	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGFR2—breast cancer	2.36e-05	0.000232	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—FN1—breast cancer	2.34e-05	0.00023	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL2—breast cancer	2.32e-05	0.000228	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NFKBIA—breast cancer	2.31e-05	0.000227	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TERT—breast cancer	2.31e-05	0.000227	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NOTCH1—breast cancer	2.29e-05	0.000225	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL2—breast cancer	2.27e-05	0.000224	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TERT—breast cancer	2.27e-05	0.000223	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FGFR1—breast cancer	2.24e-05	0.00022	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PIK3CG—breast cancer	2.24e-05	0.00022	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APC—breast cancer	2.24e-05	0.00022	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KIT—breast cancer	2.24e-05	0.00022	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EGF—breast cancer	2.21e-05	0.000218	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HIF1A—breast cancer	2.21e-05	0.000217	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FGFR1—breast cancer	2.2e-05	0.000216	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HIF1A—breast cancer	2.17e-05	0.000213	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LEP—breast cancer	2.15e-05	0.000212	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—MAPK3—breast cancer	2.14e-05	0.000211	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CAV1—breast cancer	2.13e-05	0.00021	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LEP—breast cancer	2.12e-05	0.000208	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KDR—breast cancer	2.11e-05	0.000207	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—BRAF—breast cancer	2.1e-05	0.000207	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CAV1—breast cancer	2.1e-05	0.000206	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KDR—breast cancer	2.07e-05	0.000204	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ESR1—breast cancer	2.06e-05	0.000202	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF1—breast cancer	2.05e-05	0.000202	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKT2—breast cancer	2.05e-05	0.000201	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—EGFR—breast cancer	2.04e-05	0.000201	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—FN1—breast cancer	2.03e-05	0.0002	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ESR1—breast cancer	2.02e-05	0.000199	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NFKBIA—breast cancer	2.01e-05	0.000197	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—FN1—breast cancer	1.99e-05	0.000196	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NOTCH1—breast cancer	1.99e-05	0.000195	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NFKBIA—breast cancer	1.97e-05	0.000194	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PIK3CD—breast cancer	1.97e-05	0.000194	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NOTCH1—breast cancer	1.95e-05	0.000192	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PIK3CA—breast cancer	1.95e-05	0.000192	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SERPINE1—breast cancer	1.95e-05	0.000191	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PIK3CG—breast cancer	1.94e-05	0.000191	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KIT—breast cancer	1.94e-05	0.000191	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APC—breast cancer	1.94e-05	0.000191	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—KRAS—breast cancer	1.93e-05	0.000189	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EGF—breast cancer	1.92e-05	0.000189	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APC—breast cancer	1.91e-05	0.000188	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KIT—breast cancer	1.91e-05	0.000188	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PIK3CG—breast cancer	1.91e-05	0.000188	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EGF—breast cancer	1.89e-05	0.000186	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—MAPK3—breast cancer	1.86e-05	0.000183	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NOS3—breast cancer	1.86e-05	0.000183	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—MAPK3—breast cancer	1.83e-05	0.00018	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—BRAF—breast cancer	1.83e-05	0.00018	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—BRAF—breast cancer	1.79e-05	0.000176	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1—breast cancer	1.78e-05	0.000175	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKT2—breast cancer	1.78e-05	0.000175	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—EGFR—breast cancer	1.77e-05	0.000174	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PIK3CA—breast cancer	1.77e-05	0.000174	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MDM2—breast cancer	1.76e-05	0.000173	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RAF1—breast cancer	1.76e-05	0.000173	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—RELA—breast cancer	1.75e-05	0.000172	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1—breast cancer	1.75e-05	0.000172	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKT2—breast cancer	1.75e-05	0.000172	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—EGFR—breast cancer	1.74e-05	0.000171	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ERBB2—breast cancer	1.74e-05	0.000171	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PIK3CB—breast cancer	1.72e-05	0.000169	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MTOR—breast cancer	1.72e-05	0.000169	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PIK3CD—breast cancer	1.71e-05	0.000168	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	1.69e-05	0.000166	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SERPINE1—breast cancer	1.69e-05	0.000166	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PIK3CD—breast cancer	1.68e-05	0.000165	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—KRAS—breast cancer	1.67e-05	0.000165	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	1.66e-05	0.000163	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SERPINE1—breast cancer	1.66e-05	0.000163	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL8—breast cancer	1.65e-05	0.000162	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—KRAS—breast cancer	1.64e-05	0.000162	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—HRAS—breast cancer	1.64e-05	0.000161	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NOS3—breast cancer	1.61e-05	0.000159	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CDKN1B—breast cancer	1.61e-05	0.000158	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AKT1—breast cancer	1.59e-05	0.000157	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NOS3—breast cancer	1.58e-05	0.000156	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CASP3—breast cancer	1.58e-05	0.000155	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL2—breast cancer	1.58e-05	0.000155	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—breast cancer	1.57e-05	0.000154	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	1.54e-05	0.000151	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCND1—breast cancer	1.54e-05	0.000151	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—JUN—breast cancer	1.53e-05	0.000151	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MDM2—breast cancer	1.53e-05	0.000151	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RAF1—breast cancer	1.53e-05	0.00015	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CTNNB1—breast cancer	1.52e-05	0.00015	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—RELA—breast cancer	1.52e-05	0.000149	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ERBB2—breast cancer	1.51e-05	0.000148	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	1.51e-05	0.000148	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MDM2—breast cancer	1.5e-05	0.000148	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RAF1—breast cancer	1.5e-05	0.000147	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—RELA—breast cancer	1.49e-05	0.000147	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MMP9—breast cancer	1.49e-05	0.000147	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MTOR—breast cancer	1.49e-05	0.000146	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PIK3CB—breast cancer	1.49e-05	0.000146	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CDKN1A—breast cancer	1.49e-05	0.000146	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PTEN—breast cancer	1.48e-05	0.000146	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ERBB2—breast cancer	1.48e-05	0.000146	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PIK3CB—breast cancer	1.46e-05	0.000144	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MTOR—breast cancer	1.46e-05	0.000144	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK8—breast cancer	1.45e-05	0.000143	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AKT1—breast cancer	1.45e-05	0.000142	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL8—breast cancer	1.43e-05	0.000141	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—HRAS—breast cancer	1.42e-05	0.00014	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL8—breast cancer	1.41e-05	0.000138	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CDKN1B—breast cancer	1.4e-05	0.000137	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—HRAS—breast cancer	1.4e-05	0.000137	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AKT1—breast cancer	1.38e-05	0.000136	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SRC—breast cancer	1.37e-05	0.000135	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CDKN1B—breast cancer	1.37e-05	0.000135	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CASP3—breast cancer	1.37e-05	0.000135	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL2—breast cancer	1.37e-05	0.000135	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—breast cancer	1.36e-05	0.000134	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AKT1—breast cancer	1.36e-05	0.000134	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CASP3—breast cancer	1.35e-05	0.000132	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL2—breast cancer	1.34e-05	0.000132	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—VEGFA—breast cancer	1.34e-05	0.000132	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—breast cancer	1.34e-05	0.000131	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCND1—breast cancer	1.33e-05	0.000131	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—JUN—breast cancer	1.33e-05	0.000131	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—STAT3—breast cancer	1.33e-05	0.00013	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CTNNB1—breast cancer	1.32e-05	0.00013	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCND1—breast cancer	1.31e-05	0.000129	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—JUN—breast cancer	1.31e-05	0.000128	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CTNNB1—breast cancer	1.3e-05	0.000127	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP9—breast cancer	1.29e-05	0.000127	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CDKN1A—breast cancer	1.29e-05	0.000127	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PTEN—breast cancer	1.29e-05	0.000127	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP9—breast cancer	1.27e-05	0.000125	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CDKN1A—breast cancer	1.27e-05	0.000125	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK3—breast cancer	1.27e-05	0.000125	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PTEN—breast cancer	1.26e-05	0.000124	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK8—breast cancer	1.26e-05	0.000124	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AKT1—breast cancer	1.26e-05	0.000123	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.24e-05	0.000122	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AKT1—breast cancer	1.23e-05	0.000121	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MYC—breast cancer	1.23e-05	0.000121	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TGFB1—breast cancer	1.23e-05	0.000121	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EGFR—breast cancer	1.21e-05	0.000118	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SRC—breast cancer	1.19e-05	0.000117	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SRC—breast cancer	1.17e-05	0.000115	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—VEGFA—breast cancer	1.16e-05	0.000114	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—STAT3—breast cancer	1.15e-05	0.000113	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—VEGFA—breast cancer	1.14e-05	0.000112	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KRAS—breast cancer	1.14e-05	0.000112	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—STAT3—breast cancer	1.13e-05	0.000111	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK3—breast cancer	1.1e-05	0.000108	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK3—breast cancer	1.08e-05	0.000106	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MYC—breast cancer	1.07e-05	0.000105	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFB1—breast cancer	1.07e-05	0.000105	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MYC—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFB1—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EGFR—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PIK3CA—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EGFR—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TP53—breast cancer	1.01e-05	9.95e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KRAS—breast cancer	9.89e-06	9.72e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KRAS—breast cancer	9.71e-06	9.54e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—HRAS—breast cancer	9.68e-06	9.51e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—breast cancer	9.26e-06	9.1e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	9.08e-06	8.93e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	8.92e-06	8.77e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TP53—breast cancer	8.79e-06	8.64e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TP53—breast cancer	8.63e-06	8.48e-05	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKT1—breast cancer	8.54e-06	8.4e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—HRAS—breast cancer	8.4e-06	8.26e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—HRAS—breast cancer	8.25e-06	8.11e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—breast cancer	8.04e-06	7.91e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—breast cancer	7.9e-06	7.76e-05	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKT1—breast cancer	7.42e-06	7.29e-05	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKT1—breast cancer	7.28e-06	7.16e-05	CbGpPWpGaD
